Skip to content
healthcare.dev

OXYBUTYNIN CHLORIDE

NDC 64980-531, OXYBUTYNIN CHLORIDE, tablet, from RISING PHARMA HOLDINGS, INC..

Product NDC
64980-531
Status
Listed
Labeler
RISING PHARMA HOLDINGS, INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209025
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64980-531 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYBUTYNIN CHLORIDE2.5 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
64980-531-0164980053101100 TABLET in 1 BOTTLE (64980-531-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f8ed80f2-6c3d-4d7f-b761-c2447973c1f9
  • NADAC price for package 64980053101

    GET /v1/drugs/nadac/64980053101

Use it

Look up 64980-531 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64980-531 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64980-531. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.